A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3)

Clinical trial NCT04699604 · COMPLETED

Trial details

NCT number: NCT04699604
Sponsor: Bridgette Jones
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Allergic Asthma

Start date: 2021-04-28
Primary completion: 2026-04-15
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.